S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in
ASX:PBP

Probiotec Limited (PBP.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$1.88
MA: A$1.88
A$1.88
52-Week Range N/A
Volume26,253 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield1.83%
BetaN/A
Probiotec Limited engages in the development, manufacture and sale of pharmaceuticals, consumer health, and nutraceutical products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coating; blister packing; liquids, creams, gels, and ointments and suspensions; powders and powder blending; and sprays, as well as manufacturing and packaging of finished doses. It also offers analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. In addition, the company provides packing services and formats, including foil, carded and clamshell blister packing, bottle filling, labelling, secondary packaging, and other services for the pharmaceutical, cosmetic, and food industries. Probiotec Limited was incorporated in 1996 and is headquartered in Laverton North, Australia.

MarketRank

Overall MarketRank

1.02 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.8Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 3 9278 7555
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$107.22 million
Book ValueA$0.81 per share

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Receive PBP News and Ratings via Email

Sign-up to receive the latest news and ratings for PBP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Probiotec Limited (PBP.AX) (ASX:PBP) Frequently Asked Questions

What stocks does MarketBeat like better than Probiotec Limited (PBP.AX)?

Wall Street analysts have given Probiotec Limited (PBP.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Probiotec Limited (PBP.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Probiotec Limited (PBP.AX)'s earnings last quarter?

Probiotec Limited (PBP.AX) (ASX:PBP) released its quarterly earnings data on Tuesday, February, 26th. The company reported $0.02 earnings per share (EPS) for the quarter.
View Probiotec Limited (PBP.AX)'s earnings history
.

How often does Probiotec Limited (PBP.AX) pay dividends? What is the dividend yield for Probiotec Limited (PBP.AX)?

Probiotec Limited (PBP.AX) declared a Final dividend on Friday, August 28th. Investors of record on Friday, October 30th will be given a dividend of 0.03 per share on Friday, October 30th. This represents a yield of 1.6%. The ex-dividend date of this dividend is Thursday, October 22nd. This is an increase from Probiotec Limited (PBP.AX)'s previous Final dividend of A$0.03.
View Probiotec Limited (PBP.AX)'s dividend history
.

Is Probiotec Limited (PBP.AX) a good dividend stock?

Probiotec Limited (PBP.AX) pays an annual dividend of A$0.04 per share and currently has a dividend yield of 1.83%. The dividend payout ratio of Probiotec Limited (PBP.AX) is 80.00%. Payout ratios above 75% are not desirable because they may not be sustainable.
View Probiotec Limited (PBP.AX)'s dividend history.

Who are some of Probiotec Limited (PBP.AX)'s key competitors?

What other stocks do shareholders of Probiotec Limited (PBP.AX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Probiotec Limited (PBP.AX) investors own include Kalium Lakes Limited (KLL.AX) (KLL) and 5G Networks Limited (5GN.AX) (5GN).

Who are Probiotec Limited (PBP.AX)'s key executives?

Probiotec Limited (PBP.AX)'s management team includes the following people:
  • Mr. Wesley Stringer B.Comm, LLB (Hons), CPA, CEO, MD & Exec. Director
  • Mr. Jared Stringer B.Comm, BIT, CPA, CFO, Company Sec. & Financial Controller
  • Ms. Julie McIntosh, Chief Operating Officer
  • Mr. Alan Hong, Gen. Mang. of Accounting
  • Mr. Dustin Stringer, Gen. Mang. of Marketing

What is Probiotec Limited (PBP.AX)'s stock symbol?

Probiotec Limited (PBP.AX) trades on the ASX under the ticker symbol "PBP."

How big of a company is Probiotec Limited (PBP.AX)?

Probiotec Limited (PBP.AX) has a market capitalization of $0.00 and generates $107.22 million in revenue each year.

What is Probiotec Limited (PBP.AX)'s official website?

The official website for Probiotec Limited (PBP.AX) is www.probiotec.com.au.

How can I contact Probiotec Limited (PBP.AX)?

The company can be reached via phone at 61 3 9278 7555.

This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.